iSpeak Blog

Validating the Virtual: Digital Twins as the Next Frontier in Tech Transfer and Lifecycle Assurance

Manaliben Amin
Validating the Virtual: Digital Twins as the Next Frontier in Tech Transfer and Lifecycle Assurance

Technology transfer in pharmaceuticals has long relied on meticulous paper records and countless cross-checks to prove process equivalence between sites. Each move from pilot to commercial scale often felt like starting validation all over again.

Introduction: When Tech Transfer Meets the Digital Era

Now, as manufacturing goes digital, a new question emerges:

Can manufacturing plant validation occur virtually before physical validation of a plant? 

Enter the digital twin: a data-driven replica of a process or system that mirrors its real-time behavior. Within good manufacturing practices (GMP)-regulated environments, digital twins offer something powerful: the ability to simulate, predict, and document process performance before a single batch is produced. For validation engineers and quality assurance professionals, this marks the next evolution in lifecycle assurance.

1. Understanding the Digital Twin in the GMP Context

A digital twin is more than a 3D model or dashboard. It’s a continuously updated model that synchronizes with its real-world counterpart using live process data, equipment sensors, and contextual inputs. In pharmaceutical operations, this could mean a virtual bioreactor or a predictive model for filtration performance that learns from every production run.

What sets it apart from legacy modeling tools is its bidirectional feedback loop the twin doesn’t just predict; it learns and adapts. That makes it invaluable for tech transfer, where differences in scale, utilities, or local conditions can affect yield and product quality.

A digital twin can test these “what-if” scenarios safely in silico, flag potential deviations, and even generate validation evidence that aligns with ISPE GAMP® 5 Guide (Second Edition) and ICH Q12 principles.

 

Image
ispeak
Figure1: Pharmaceutical Digital Twin Platform - Integrating Virtual and Physical Operations

 

2. Why Tech Transfer Still Hurts—and How Digital Twins Can Help

Every engineer who has handled a tech transfer knows the pain points: incomplete knowledge, inconsistent documentation, and delayed comparability assessments. Even in digital environments, data silos persist between development, manufacturing, and QA.

A digital twin solves this by creating a continuous data thread. Instead of hand-offs between stages development, scale-up, commercial the twin evolves. Adjustments to critical process parameters (CPPs) or critical quality attributes (CQAs) are captured, analyzed, and validated virtually before implementation.

For example, a digital twin might simulate fluid dynamics to predict shear stress on cell cultures, reducing trial batches and qualification cycles.

3. Virtual Validation in Action: A Practical View

Imagine a biologics manufacturer transferring a monoclonal antibody process. Using a validated digital twin built from historical process data, the tech-transfer team runs hundreds of simulations on temperature, agitation, and pH.

The model identifies a parameter window that cuts variability by 15%. When the receiving site executes its process performance qualification (PPQ), the results align with those predictions, saving two months of troubleshooting.

All simulated results and control strategies flow directly into a paperless validation system. The result is evidence-based confidence that meets both engineering and regulatory expectations.

4. Regulatory Alignment: From Models to Trustworthy Evidence

Digital twin validation naturally raises a critical question: Will regulators accept it?

The encouraging answer is “yes-if it’s justified.” US Food and Drug Administration (US FDA) and European Medicines Agency (EMA) guidance increasingly emphasize risk-based validation and scientific soundness over volume of documentation. Under the emerging framework of computer software assurance (CSA), the focus shifts from testing everything to proving what matters most.

For digital twins, this means defining:

  • The intended use of the model (predictive vs. control)
  • Data-quality controls and governance
  • Verification that simulated outcomes mirror real-world behavior

A validated digital twin isn’t a black box, it’s a transparent, traceable system. When coupled with proper version control, data integrity checks, and ongoing performance verification, it aligns seamlessly with Part 11 and Annex 11 expectations. The digital twin continuously feeds predictive insights and data integrity evidence back into each validation phase, enabling continuous assurance throughout the system lifecycle.

 

Image
ispeak
Figure 2. Validation V-Model with Digital Twin Feedback Loop 

 

5. Lifecycle Continuity: Validation That Doesn’t Expire

Traditional validation tends to be episodic conducted at a moment in time, frozen in binders. A digital twin changes that rhythm. It supports continuous validation, where the model monitors critical parameters and compares them with the qualified design space in real time.

When process drift is detected, the system can automatically initiate a deviation assessment or corrective and preventive actions (CAPA) workflow in the e-validation platform. This dynamic approach keeps validation “alive,” enabling teams to maintain a validated state across the entire lifecycle, not just at qualification milestones.

Benefits include: 

  • Faster change implementation
  • Reduced re-qualification effort
  • Early visibility into process degradation trends

 

Image
ispeak
Figure 3: Lifecycle Continuity Framework for Digital Twin Validation

 

6. Governance, Culture, and Data Integrity

Technology alone isn’t enough. For digital twin validation to succeed, organizations must establish governance models that define ownership, data-sharing policies, and review frequency.

Quality leaders should treat twins as controlled systems-subject to the same rigor as laboratory or manufacturing software. Engineering teams must document model assumptions, while QA ensures that validation evidence remains reviewable and audit ready.

Equally important is culture. Validation professionals need to move from “prove compliance through paperwork” to “demonstrate control through insight.” That shift involves education, trust, and collaboration between data scientists, process engineers, and QA.

7. The Road Ahead: Digital Maturity and Regulatory Confidence

ISPE’s Pharma 4.0™ Operating Model provides a practical framework for this evolution. Digital twins sit naturally in the digitalized and adaptive maturity stages where organizations integrate real-time data into decision-making.

Looking forward, harmonized standards are likely to emerge around digital twin governance, model validation, and cybersecurity. Early adopters will gain not only operational efficiency but also regulatory goodwill as agencies increasingly favor science-based, data-rich validation strategies.

For the next generation of validation engineers, mastering these tools won’t be optional, it will define professional excellence.

Conclusion: Making the Virtual Real

Digital twin validation isn’t about replacing human judgment or traditional protocols—it’s about enhancing them. By allowing engineers to test, learn, and validate in a virtual space, we reduce risk before it reaches production.

In a world where time-to-market and compliance agility determine competitive edge, validating the virtual may soon become the most real advantage of all.

Disclaimer

iSpeak Blog posts provide an opportunity for the dissemination of ideas and opinions on topics impacting the pharmaceutical industry. Ideas and opinions expressed in iSpeak Blog posts are those of the author(s) and publication thereof does not imply endorsement by ISPE.


Submit Your Best Content to ISPE

ISPE’s official blog, iSpeak accepts contributions from our Members and professionals in the pharma industry.  

What We Look For